Skip to content

Pharminent

cropped-ChatGPT-Image-May-28-2026-10_46_23-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Policy / Pricing
  • Hospital Prices Have Risen Much Faster for Private Insurance Than Medicare Since 2019
  • Policy / Pricing

Hospital Prices Have Risen Much Faster for Private Insurance Than Medicare Since 2019

KFF Medicare

This brief compares the prices paid by private insurers for hospital care to increases in Medicare payment using data from the Bureau of Labor Statistics (BLS) Producer Price Index (PPI), finding that

Read full story

pharminent May 18, 2026 (Last updated: May 19, 2026)

KFF Medicare

This brief compares the prices paid by private insurers for hospital care to increases in Medicare payment using data from the Bureau of Labor Statistics (BLS) Producer Price Index (PPI), finding that

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: AstraZeneca wins nod for blood pressure pill, opening new class of hypertension drugs
Next: Regeneron, Parabilis set out to create new drug class in deal worth up to $2.3B

Related Stories

  • Policy / Pricing

The next FDA commissioner must be a champion for gene therapies

pharminent June 5, 2026
  • Policy / Pricing

Stakeholders want Makary’s voucher program paused, call for FDA independence

pharminent June 5, 2026
  • Policy / Pricing

SCOTUS backs generic firm Hikma in skinny label dispute

pharminent June 4, 2026

You May Have Missed

  • M&A / Deals

Alzecure enters collaboration and with Lilly for Alzheimer’s project

pharminent June 9, 2026
  • Clinical Data

ADA: AstraZeneca hands Structure a win with ‘relatively underwhelming’ GLP-1 pill data

pharminent June 9, 2026
  • M&A / Deals

GSK pays $10.6B for cancer biotech Nuvalent in industry’s second-biggest buy of the year

pharminent June 9, 2026
  • Regulatory

ADA: Lilly bests Novo again, takes GLP-1 pill Foundayo to FDA for diabetes approval

pharminent June 9, 2026
Copyright © 2026 All rights reserved. | ReviewNews by AF themes.